
Royal Philips announced that Carla Goulart Peron, its Chief Medical Officer, has been appointed to the Board of Directors of the Medical Device Innovation Consortium (MDIC). MDIC is a public-private partnership that collaborates with the FDA and other agencies to accelerate patient access to innovative medical devices. Dr. Peron brings over 15 years of medical technology leadership and will help strengthen MDIC’s efforts in regulatory science, quality standards, and patient safety. This appointment aligns with Philips’ commitment to advancing healthcare innovation and improving patient outcomes globally.